Cited 0 times in 
Cited 0 times in 
Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2023-06-02T01:04:12Z | - |
| dc.date.available | 2023-06-02T01:04:12Z | - |
| dc.date.issued | 2022-06 | - |
| dc.identifier.issn | 0923-7534 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194629 | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Oxford University Press | - |
| dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | A. He | - |
| dc.contributor.googleauthor | J. Valle | - |
| dc.contributor.googleauthor | C. Lee | - |
| dc.contributor.googleauthor | M. Ikeda | - |
| dc.contributor.googleauthor | P. Potemski | - |
| dc.contributor.googleauthor | C. Morizane | - |
| dc.contributor.googleauthor | J. Cundom | - |
| dc.contributor.googleauthor | D. Tougeron | - |
| dc.contributor.googleauthor | F. Dayyani | - |
| dc.contributor.googleauthor | N. Rokutanda | - |
| dc.contributor.googleauthor | J. Xiong | - |
| dc.contributor.googleauthor | G. Cohen | - |
| dc.contributor.googleauthor | D. Oh | - |
| dc.identifier.doi | 10.1016/j.annonc.2022.04.442 | - |
| dc.relation.journalcode | J00171 | - |
| dc.identifier.eissn | 1569-8041 | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422011322 | - |
| dc.citation.volume | 33 | - |
| dc.citation.number | Suppl 4 | - |
| dc.citation.startPage | S378 | - |
| dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 4) : S378, 2022-06 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.